Trials / Completed
CompletedNCT05473130
Breethe Abiomed Recovery RegisTry (BART)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Abiomed Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The BART Registry intended to utilize observational data of the Abiomed Breethe OXY-1 System™ in real-world settings to drive best practice usage patterns, serve as a tool to measure and improve the quality of patient care and as a resource to inform us on the design of future studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Breethe Oxy-1 System | To pump, oxygenate, and remove carbon dioxide from blood during cardiopulmonary bypass with Breethe Oxy-1 System |
Timeline
- Start date
- 2021-03-31
- Primary completion
- 2024-04-02
- Completion
- 2024-04-02
- First posted
- 2022-07-25
- Last updated
- 2024-09-04
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05473130. Inclusion in this directory is not an endorsement.